+1 (888) 485-6340
  • Home
  • Contact Us
  • Sign Up for Email Alert
  • Careers
Briacell
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
    Menu
    • About Us
      • Corporate Profile
      • Board of Directors
      • Management
      • Scientific Advisory Board
      • Business Development
      • Careers
      • Email Alerts
      • Contact Us
      • Close
    • Technology
      • Bria-IMT™
      • Bria-OTS™
      • BriaDx™
      • PKCδ
      • Patents
      • Mechanism of Action
      • Clinical Trials
      • Close
    • In the News
      • Recent News
      • Recent Events
      • Close
    • Investor Relations
      • Presentations
      • Corporate Governance
      • News and Events
      • Filings
      • Annual Report
      • Shareholder Information
      • FAQ
      • Email Alerts
      • Contact Us
      • Close

Hired Dr. M. Lacher –Head of R&D -an expert in immuno-oncology & diagnostics

Posted on July 15, 2015November 2, 2018 by Alexander

2015 Jul 15

Hired Dr. M. Lacher –Head of R&D -an expert in immuno-oncology & diagnostics

This entry was posted in Recent News. Bookmark the permalink.
BriaCell begins trading on the OTCQB (BCTXF)
BriaCell Launches Development of Companion Diagnostic Product, BriaDx(TM)
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Recent News

  • BriaCell Appoints Jamieson Bondarenko to its Board of Directors February 12, 2019
  • BriaCell Announces Switch to Novel Frozen Formulation for Lead Cancer Drug Candidate, Upcoming Attendance at Biotech Showcase™ 2019 and Presentation at Keystone Symposia Conference January 2, 2019
  • BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA® at a Major Breast Cancer Conference December 6, 2018
  • UPDATED – BriaCell to Present Updated Clinical Data Including Early Safety Data in KEYTRUDA® Combination Study and Positive Phase IIa Monotherapy Efficacy Data at 2018 San Antonio Breast Cancer Symposium November 20, 2018
  • BriaCell to Present Updated Clinical Data Including Early Safety Data in KEYTRUDA® Combination Study and Positive Phase IIa Monotherapy Efficacy Data at 2018 San Antonio Breast Cancer Symposium November 19, 2018

Categories

  • Annual Reports
  • News and Events
    • Recent Events
    • Recent News

Archives

  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • November 2015
  • October 2015
  • September 2015
  • July 2015
  • June 2015
  • January 2015
  • November 2014
  • April 2014

Corporate Office- Canada
Suite 300 - Bellevue Centre
235 -15th Street
West Vancouver, BC V7T 2X1
Tel: 604-921-1810
Fax: 604-921-1898

Corporate Office- US
820 Heinz Avenue
Berkeley, CA, 94710
Tel: 1-888-485-6340
Fax: 424-245-3719

About Us

  • Corporate Profile
  • Board of Directors
  • Management
  • Business Development
  • Careers
  • Email Alerts
  • Contact Us

Technology

  • Bria-IMT™
  • Bria-OTS™
  • BriaDx™
  • PKCδ
  • Patents
  • Mechanism of Action
  • Clinical Trials

Investor Relations

  • Presentations
  • Corporate Governance
  • News and Events
  • Filings
  • Annual Report
  • Shareholder Information
  • Email Alerts
  • Contact Us

Signup for our Email Alert!

Copyright 2019 © Briacell.
  • Generic selectors
    Exact matches only
    Search in title
    Search in content
    Search in posts
    Search in pages
  • About Us
    • Corporate Profile
    • Board of Directors
    • Management
    • Scientific Advisory Board
    • Business Development
    • Careers
    • Email Alerts
    • Contact Us
  • Technology
    • Bria-IMT™
    • Bria-OTS™
    • BriaDx™
    • PKCδ
    • Patents
    • Mechanism of Action
    • Clinical Trials
  • In the News
    • Recent News
    • Recent Events
  • Investor Relations
    • Presentations
    • Corporate Governance
    • News and Events
    • Filings
    • Annual Report
    • Shareholder Information
    • FAQ
    • Email Alerts
    • Contact Us
  • Home
  • Contact Us
  • Sign Up for Email Alert
  • Careers